Deal Intelligence Platform & Services for Global M&A / PE
2021 brought a flurry of #MnA activity in the life sciences sector, followed by a slowdown in 2022. Here’s why dealmaking could pick up again. deloi.tt/3PIOHZP
– Deloitte M&A (@DeloitteMnA)09:00 – Aug 31, 2022
Novo Nordisk entered a partnership worth up to $2.1 billion with Vivtex Corp. to develop next-generation oral medicines for obesity and diabetes, leveraging Vivtex's drug delivery technology to...
null GlaxoSmithKline announced today that it has acquired 35Pharma Inc., a Montreal-based clinical-stage biopharmaceutical company, for $950 million in cash. The deal grants GSK access to HS235, an...
null Danaher Corporation has agreed to acquire Masimo Corporation for $180 per share in an all-cash transaction valued at approximately $9.9 billion, marking a significant consolidation move in the...
Humana Inc. is in advanced talks to acquire Sarasota, Florida-based MaxHealth, a primary care network, in a deal approaching $1 billion, according to Bloomberg reports. The transaction underscores...